BOSTON SCIENTIFIC CORP 4
4 · BOSTON SCIENTIFIC CORP · Filed Jan 2, 2015
Insider Transaction Report
Form 4
Onuscheck John Michael
SVP & Pres-Neuromodulation
Transactions
- Exercise/Conversion
Performance Share Units
2015-01-01−25,875→ 0 totalFrom: 2014-12-31Exp: 2014-12-31→ Common Stock (25,875 underlying) - Tax Payment
Common Stock
2015-01-01$13.25/sh−13,505$178,941→ 116,025 total - Exercise/Conversion
Common Stock
2015-01-01+25,875→ 129,530 total
Footnotes (2)
- [F1]On February 27, 2012, the reporting person was awarded a target number of performance share units under the Company's 2012 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2012 adjusted free cash flow measured against its 2012 financial plan over the one-year performance period ending December 31, 2012 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2013, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2014.
- [F2]Each performance share unit represented the Company's commitment to issue one share of Boston Scientific common stock.